SAU : 4002.SR

Mouwasat Medical Services Company

$60.25 SAR

$0.25 (0.42%)

Volume
189.94K
Average Volume
351.25K
Market Capitalization
$12.05B
P/E Ratio
14.59
Dividend Yield
3.53%
Price Target
Year High
$79.75
Year Low
$58.65
Day High
—
Day Low
—
Payout Ratio
$0.73
Current Ratio
$1.62
Company Overview

SAU

Nasser Sultan Al-Hammad Al-Subaie

Medical - Care Facilities

Healthcare

4002.SR

4084

SA

SAR

https://www.mouwasat.com

966 13 820 0000

N/A

N/A

Liquidity Metrics

0.29

1.62

1.40

0.41

0.73

Sales & Valuation

$3.22B

3.66

3.01

22.49

2.69

Profitability

$4.11

$822.04M

25.09%

26.58%

21.94%

12.66%

P/E Metrics

14.59

0.64

0.64

Analyst Price Target & Rating

Buy

4/5

0 Analysts

%

Financial Health Scores

4.39

6/9

$712.1M

$6.53B

$2.4B

$859.97M

Key Metrics (TTM)

No key metrics data available.

Company Executives
Name Title
Ahmed Abdulfattah Touman Chief Pharmacist
Nasser Sultan Al-Hammad Al-Subaie Vice-Chairman & Chief Executive Officer
Khaled Bin Suleiman Al-Saleem MD & Executive Director
Yusuf Ahmad Sulaiman Board of Director's Secretary & Chief Financial Officer
Poll Results

No votes yet today — be the first to share your view!

About Mouwasat Medical Services Company (SAU:4002.SR) Stock

Mouwasat Medical Services Company, established in 1974 and headquartered in Dammam, Saudi Arabia, is a prominent healthcare provider. The company's core activities involve the acquisition, management, and operation of a wide array of medical facilities, including hospitals, clinics, pharmacies, and drugstores throughout the Kingdom of Saudi Arabia. Mouwasat operates an extensive chain of hospitals located in key cities such as Dammam, Jubail, Madinah, Khobar, Qatif, and Riyadh, delivering comprehensive medical care to its patients. Beyond general hospital services, the company features specialized centers addressing various health needs. These include dedicated skin care facilities offering cosmetic dermatology, laser treatments, reconstructive and plastic surgery, beauty services, and wei ... ght loss programs. It also provides a fertility center and a specialized clinic for bariatric surgery. Further expanding its specialized offerings, Mouwasat boasts a cardiology center for the diagnosis and treatment of heart conditions, a dedicated stroke unit, and a facility focused on managing diabetes and diabetic foot complications. The company also extends its services to include long-term care and rehabilitation. Additionally, Mouwasat Medical Services Company is active in the wholesale distribution of medical equipment and pharmaceutical products.

Frequently Asked Questions

What is the current Mouwasat Medical Services Company (4002.SR) stock price?

Mouwasat Medical Services Company(SAU:4002.SR) stock price is $60.25 in the last trading session. During the trading session, 4002.SR stock reached the peak price of $79.75 while $58.65 was the lowest point it dropped to. The percentage change in 4002.SR stock occurred in the recent session was 0.42% while the dollar amount for the price change in 4002.SR stock was $0.25.

4002.SR's industry and sector of operation?

The SAU listed 4002.SR is part of Medical - Care Facilities industry that operates in the broader Healthcare sector.

Who are the executives of 4002.SR?

Ahmed Abdulfattah Touman | Chief Pharmacist
Nasser Sultan Al-Hammad Al-Subaie | Vice-Chairman & Chief Executive Officer
Khaled Bin Suleiman Al-Saleem | MD & Executive Director
Yusuf Ahmad Sulaiman | Board of Director's Secretary & Chief Financial Officer
|

How many employees does 4002.SR have?

Number of 4002.SR employees currently stands at 4084. 4002.SR operates from Destect 71 - King Fahad Road, Dammam, Eastern Province 31411, SA.

Link for 4002.SR official website?

Official Website of 4002.SR is: https://www.mouwasat.com

How do I contact 4002.SR?

4002.SR could be contacted at phone #966 13 820 0000 and can also be accessed through its website. 4002.SR operates from Destect 71 - King Fahad Road, Dammam, Eastern Province 31411, SA.

How many shares of 4002.SR are traded daily?

The average number of 4002.SR shares traded daily for last 3 months was 351.25K.

What is the market cap of 4002.SR currently?

The market value of 4002.SR currently stands at $12.05B with its latest stock price at $60.25